Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 16, 2022
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
Greg Harrison Maintained (STOK) at Strong Buy with Decreased Target to $40 on, Mar 16th, 2022
Greg Harrison of B of A Securities, Maintained "Stoke Therapeutics, Inc." (STOK) at Strong Buy with Decreased Target from $43 to $40 on, Mar 16th, 2022.
Greg has made no other calls on STOK in the last 4 months.
There are 2 other peers that have a rating on STOK. Out of the 2 peers that are also analyzing STOK, 0 agree with Greg's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Greg
- Suji Jeong of "Jefferies" Initiated at Strong Buy and Held Target at $50 on, Monday, January 31st, 2022
- Jessica Fye of "JP Morgan" Upgraded from Hold to Buy and Held Target at $41 on, Monday, November 22nd, 2021
